MCMedicalCodingSoftware
J7527

J7527: Everolimus, oral, 0.25 mg

HCPCSActiveBETOS O1G

J7527 is a HCPCS Level II code for everolimus, oral, 0.25 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits: units per day

The most units of J7527 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
40 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
outpatient
40 units
MAI 3: Date of Service Edit: Clinical · Prescribing Information
DME supplier
960 units
MAI 3: Date of Service Edit: Clinical · Clinical: Data

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for J7527

Long descriptor
Everolimus, oral, 0.25 mg

The official wording. This is what the code means.

Short descriptor
Oral everolimus

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2013

When CMS introduced the code.

BETOS
O1G

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J7527

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J7527 is not quite right, the correct code is very often within a few positions of it.

  • J7517Mycophenolate mofetil, oral, 250 mgterminated
  • J7518Mycophenolic acid, oral, 180 mg
  • J7519Injection, mycophenolate mofetil, 10 mgterminated
  • J7520Sirolimus, oral, 1 mg
  • J7521Tacrolimus, granules, oral suspension, 0.1 mg
  • J7524Mycophenolate mofetil, oral, 5 mg
  • J7525Tacrolimus, parenteral, 5 mg
  • J7526Injection, mycophenolate mofetil, 5 mg
  • J7528Mycophenolate mofetil, for suspension, oral, 100 mgterminated
  • J7529Mycophenolate mofetil, for suspension, oral, 5 mg
  • J7530Mycophenolate mofetil (myhibbin), oral suspension, 5 mg
  • J7531Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
  • J7599Immunosuppressive drug, not otherwise classified
  • J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
  • J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
  • J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
HCPCS Level II2026Q4-Oct· effective October 1, 2026